Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Manufacturing
Bridging the Gap
Third party operations, says Kurt Reber, have created complexity in the management of overall performance at Novartis. In response to the challenge, the company has set up an organization that monitors the integration of any third party manufacturer into Novartis' global network.
Keeping It Simple
Innovative facility design, believes Ulrich Rudow, is about simplifying processes. NGP spoke with the Vice President of Worldwide Engineering & Real Estate at Johnson&Johnson about raising the bar without adding complexity.
Better Be Safe
After drug manufacturer Merck acquired the Swiss biotech company Serono one year ago, Laurent Foetisch became Head of Supply Chain at Merck Serono.
The Latest RFID Solutions to Protect the Supply Chain
An interview with Andre Cote, Senior Director of Business Development, Checkpoint Systems, Inc.
Victories in Manufacturing and Regulatory Compliance
The WelChol story, a case study by Kristine Senft, Senior Vice President of Marketing and Sales for DSM Pharma Chemicals.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.